Interferon Regulatory Factor 2 Binding Protein 2b Regulates Neutrophil Versus Macrophage Fate During Zebrafish Definitive Myelopoiesis

Luxiang Wang,Shuo Gao,Haihong Wang,Chang Xue,Xiaohui Liu,Hao Yuan,Zixuan Wang,Saijuan Chen,Zhu Chen,Hugues de The,Yiyue Zhang,Wenqing Zhang,Jun Zhu,Jun Zhou
DOI: https://doi.org/10.3324/haematol.2019.217596
2019-01-01
Haematologica
Abstract:Aproper choice of neutrophil-macrophage progenitor cell fate is essential for the generation of adequate myeloid subpopulations during embryonic development and in adulthood. The network governing neutrophil-macrophage progenitor cell fate has several key determinants, such as myeloid master regulators CCAAT enhancer binding protein alpha (C/EBPα) and spleen focus forming virus proviral integration oncogene (PU.1). Nevertheless, more regulators remain to be identified and characterized. To ensure balanced commitment of neutrophil-macrophage progenitors toward each lineage, the interplay among these determinants is not only synergistic, but also antagonistic. Depletion of interferon regulatory factor 2 binding protein 2b (Irf2bp2b), a well-known negative transcription regulator, results in a bias in neutrophil-macrophage progenitor cell fate in favor of macrophages at the expense of neutrophils during the stage of definitive myelopoiesis in zebrafish embryos. Mechanistic studies indicate that Irf2bp2b acts as a downstream target of C/EBPα, repressing PU.1 expression, and that SUMOylation confers the repressive function of Irf2bp2b. Thus, Irf2bp2b is a novel determinant in the choice of fate of neutrophil-macrophage progenitor cells.
What problem does this paper attempt to address?